Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-14

FDA Approved: ADAPALENE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Adapalene by Sun Pharmaceutical Industries. The action concerns the product's approved indication for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene (Adapalene)

Snippet

SUPPL AP for ADAPALENE (ADAPALENE)